Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer – The Scientist
The Scientist |
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
The Scientist In the melanoma trial, around 90 percent of patients with advanced cancer experienced a pause in disease progression after two years of treatment with the immunotherapy drug. The lung cancer data came from two trials. One included 1,274 cases of … Merck cements its position as dominant developer of immunotherapy |
